Plaintiffs involved in pending mass tort litigation over hormone replacement therapy may admit evidence from key expert witnesses, a judge presiding over the litigation has ruled. In the ruling, Philadelphia Common Pleas Judge Sandra Mazer rejected arguments by the defense that the experts’ methodologies were flawed. Plaintiffs allege that they developed breast cancer after taking hormone replacement drugs.